Delivery Order SPE2DB22D3301-SPE2DB25FY4FK
Award Date
5/2/25
Potential Completion Date
5/5/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,090.97, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside delivery order with a completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a firm fixed price of $2,657.05 and a completion date of July 30, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,496.37, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The order has an ultimate completion date of April 20, 2023 and was awarded on April 19, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, at a ceiling value of $16,606.00. The contract is a firm fixed-price delivery order with an ultimate completion date of May 31, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a ceiling value of $5,501.12 and a period of performance through April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The $1,693.70 firm fixed price contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has a total ceiling value of $1,423.71 and an ultimate completion date of September 24, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,905.73, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine, to support military healthcare programs. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 16, 2025. The IDC, valued up to $999,999,999, serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The $6,642.40 firm fixed-price contract has an ultimate completion date of August 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024. The $6,708.40 firm fixed-price contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a hepatitis B vaccine. The contract has an ultimate completion date of October 30, 2024 and is not associated with any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...